Delivery Order SPE2DB22D1017-SPE2DB24FF4NL
- Not listed
- This federal contract award, valued at $3,710.04, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of 4566043689 - TACROLIMUS 1 MG CAPSULE (IR) 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 8, 2024. This award is not set-aside and is part of Amerisourcebergen's larger Indefinite...
- This federal contract award, valued at $2,201.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for 4,567,996,433 units of the medication Tacrolimus 5 mg Capsule (IR) 100s, with a completion date of April 23, 2025. The contract is a firm fixed-price, non-set-aside arrangement. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $4,973.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tacrolimus 1 mg capsules, an immunosuppressant medication, in quantities of 100 capsules per bottle. The contract has an ultimate completion date of January 16, 2025 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order, valued at $4,361.18, is for the provision of 100 units of the pharmaceutical drug Tacrolimus 1 mg capsules. This order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver...
- This federal contract award is for the delivery of Tacrolimus 1mg capsules to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that serves as a prime contractor for various government agencies, including the Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract is a delivery order with a firm fixed price of $1,040.88 and a period of...
- This federal contract award is for the delivery of 100 capsules of the medication Tacrolimus 0.5 mg (immediate release) to the Defense Logistics Agency (DLA). The contract, a firm fixed-price delivery order valued at $1,856.62, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of October 21,...
- This federal contract award, with a ceiling value of $1,146.73, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of Tacrolimus 1 mg capsules, a specialty pharmaceutical product, and takes the form of a firm fixed price delivery order with a period of performance through March 11, 2024. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,420.57 firm fixed-price delivery order contract covers the supply of Tacrolimus 1 mg capsules (immediate release) to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
- This federal contract award, valued at $1,221.19, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TACROLIMUS 1 MG CAPSULE (IR) 100S, a prescription medication. The contract has an ultimate completion date of March 3, 2025 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,514.24 firm fixed-price delivery order is for the supply of 100 units of the drug Tacrolimus 5 mg capsules, an immunosuppressant medication. The contract has an ultimate completion date of July 25, 2024 and is not designated as a set-aside. This award is associated with a larger Indefinite Delivery Contract (IDC)...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF4NLDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, a delivery order with a firm fixed price, is for the delivery of 4,564,016,254 units of Tacrolimus 1 mg capsules (immediate release) in 100-count bottles. The award has a ceiling value of $3,238.28 and a completion date of March 20, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 3/19/24 |